BACKGROUND: This exploratory, hypothesis-generating study aimed to evaluate the potential genetically informed association between CD300C gene expression and lung adenocarcinoma (LUAD) risk, and to investigate the possible mediating role of CD62L− monocytes using a multi-omics Mendelian randomization (MR) framework. This evidence concerns the gene CD300C and lung adenocarcinoma.